...
首页> 外文期刊>Pan African Medical Journal >Percutaneous transhepatic biliary stent placement in the palliative management of malignant obstructive jaundice: initial experience in a tertiary center in Ghana
【24h】

Percutaneous transhepatic biliary stent placement in the palliative management of malignant obstructive jaundice: initial experience in a tertiary center in Ghana

机译:恶性梗阻性黄疸的姑息管理中经皮的经皮胆道支架展示:加纳的大学中心的初步经验

获取原文
           

摘要

Introduction:one of the mainstays of management of malignant biliary obstruction is the decompression of the biliary system and its associated obstructive symptoms. Non-surgical palliative treatment such as percutaneous transhepatic biliary stenting is desirable in many selected patients. However, this service is often not available in many resource-limited countries. We share our initial experience of percutaneous transhepatic biliary stenting for the management of malignant biliary obstruction in our first set of patients with surgically non resectable malignant biliary obstruction in Ghana.Methods:percutaneous transhepatic biliary stenting was performed on the first 23 consecutive patients at the Korle Bu Teaching Hospital. The procedure served as the first palliation for malignant obstruction through interventional radiology. Medical records as well as serum levels of total bilirubin (TBil), aspartate aminotransferase (AST), alanine aminotransferase (ALT) and alkaline phosphatase (ALP) were used to assess the efficiency of the intervention. Microsoft Excel 2010 was used to analysis the data.Results:most patients had resolution of jaundice with marked improvement in liver function and resolution of the itching associated with obstructive jaundice. During the follow-up of cases, one major complication of hemoperitoneum occurred requiring laparotomy. No other major complications such as bile leakage or death occurred. Four (4) patients had sepsis, which was managed.Conclusion:the introduction of the intervention in Ghana has proven to valuable for palliative drainage and relief of obstructive symptoms, hence contributing to better patient management. It is relatively safe with minor complications among Ghanaians with non-resectable obstructive symptoms.Copyright: Benjamin Dabo Sarkodie et al.
机译:简介:恶性胆管梗阻管理的一个主干是胆道系统的减压及其相关的阻塞性症状。在许多选定的患者中,希望诸如经皮的胰胆汁支架如经皮的姑末的姑息治疗。但是,这项服务通常在许多资源有限的国家通常不可用。我们分享我们的初始经验,对我们的第一组患者在加纳的手术不可切除恶性胆道阻塞的第一组患者中进行经皮胆汁障碍的初步体验。方法:经皮肝胆汁支架在韩格的前23名连续患者上进行Bu教学医院。该方法作为介入放射学通过介入放射学的恶性障碍的第一次粘土。使用医疗记录以及总胆红素(Tbil),天冬氨酸氨基转移酶(AST),丙氨酸氨基转移酶(ALT)和碱性磷酸酶(ALP)的血清水平用于评估干预的效率。 Microsoft Excel 2010用于分析数据。结果:大多数患者已经解决了黄疸,具有显着改善的肝功能和与阻塞性黄疸相关的瘙痒的分辨率。在随访的情况下,血管基因的一个主要并发症发生了腹腔切开术。没有其他主要并发症,如胆汁泄漏或死亡。四(4)例患者患有败血症,其管理。结论:引入加纳的干预已被证明对姑息性引流和缓解阻塞性症状的有价值,因此有助于更好的患者管理。在加纳人之间具有少量并发症,具有不可切除的阻塞性症状的轻微并发症是相对安全的.Copyright:Benjamin Dabo Sarkodie等。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号